Modulation of the tumor growth and metastasis effect through inhibiting PTTG1 up-regulation and PI3K/AKT activation mediated by PTTG3P suppression might be used as a potential target for HCC prevention and therapy. This evidence concerns the gene PTTG3P and neoplasm.